Navigation For Mobile
  2. >
  3. 2021
  4. >
  5. March

Monthly Archives: March 2021

Overcoming the Challenges of API Complexity

Posted on March 15, 2021 by

Pharmaceutical drug molecules are becoming increasingly complex, posing challenges in formulation development and manufacturing. This is particularly true of small molecule drug APIs and peptides, both of which have a…

Posted in API synthesis, APIs, atom economy, Chemistry, corporate stewardship, drugs, Effluent, EHS, energy conservation, energy effciency, green chemistry, Neuland Labs | Tagged , , , , | Comments Off on Overcoming the Challenges of API Complexity

Weighing the Potential for APIs and Finished Dosage Forms in Emerging Markets

Posted on March 1, 2021 by

New markets for drug manufacturers are emerging worldwide in regions that have typically purchased and imported drugs in finished dosage forms. While this shift has been underway for a few…

Posted in API synthesis, APIs, Chemistry, Contract Manufacturing, drugs, generic, Neuland Labs, supply chain | Tagged , , , , , | Comments Off on Weighing the Potential for APIs and Finished Dosage Forms in Emerging Markets